Neuberger Berman Group
SLXNW

Neuberger Berman Group’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Neuberger Berman Group’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$641 Hold
31,552
– – ﹤0.01% 2161
2025
Q4 		$820 Hold
31,552
– – ﹤0.01% 2110
2025
Q3 		$1.11K Hold
31,552
– – ﹤0.01% 2029
2025
Q2 		$1.29K Hold
31,552
– – ﹤0.01% 2048
2025
Q1 		$2.41K Hold
31,552
– – ﹤0.01% 1971
2024
Q4 		$1.07K Hold
31,552
– – ﹤0.01% 1925
2024
Q3 		$1K Buy
+31,552
New +$1.83K ﹤0.01% 1924

Other funds holding SLXNW

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

Neuberger Berman Group's SLXNW Position: Q1 2026 in Review

Neuberger Berman Group held its Silexion Therapeutics Warrant (SLXNW) position steady in Q1 2026 at 31,552 shares worth $641. The position accounts for ﹤0.01% of the portfolio, ranked #2161.

Neuberger Berman Group first reported a position in SLXNW in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.41K in Q1 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q1 2026.

  • Neuberger Berman Group held 31,552 shares of Silexion Therapeutics Warrant worth $641 as of Q1 2026.
  • Neuberger Berman Group left its Silexion Therapeutics Warrant share count unchanged in Q1 2026.
  • Silexion Therapeutics Warrant made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #2161 holding.
  • Neuberger Berman Group first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 7 quarters since.
  • Neuberger Berman Group's Silexion Therapeutics Warrant position peaked at $2.41K in Q1 2025.
  • 19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.